Cancer Monoclonal Antibodies Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4164303
- 102 Pages
- January 2020
- Medical Devices
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Cancer Monoclonal Antibodies market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Cancer Monoclonal Antibodies market segmented into
Naked mAbs
Conjugated mAbs
Based on the end-use, the global Cancer Monoclonal Antibodies market classified into
Hospitals
Retail Pharmacies
Based on geography, the global Cancer Monoclonal Antibodies market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
F. Hoffmann-La Roche
Amgen
Bristol-Myers Squibb
Takeda Pharmaceuticals
Pfizer
Merck
Eli Lilly
Sanofi
Janssen Biotech
Novartis
AbbVie
Boehringer Ingelheim
AstraZeneca
Bayer
Biogen
TG Therapeutics
CTI BioPharma
Intas Pharmaceuticals
Kyowa Hakko Kirin
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CANCER MONOCLONAL ANTIBODIES INDUSTRY
2.1 Summary about Cancer Monoclonal Antibodies Industry
2.2 Cancer Monoclonal Antibodies Market Trends
2.2.1 Cancer Monoclonal Antibodies Production & Consumption Trends
2.2.2 Cancer Monoclonal Antibodies Demand Structure Trends
2.3 Cancer Monoclonal Antibodies Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Naked mAbs
4.2.2 Conjugated mAbs
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Retail Pharmacies
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Naked mAbs
5.2.2 Conjugated mAbs
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Retail Pharmacies
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Naked mAbs
6.2.2 Conjugated mAbs
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Retail Pharmacies
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Naked mAbs
7.2.2 Conjugated mAbs
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Retail Pharmacies
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Naked mAbs
8.2.2 Conjugated mAbs
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Retail Pharmacies
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Naked mAbs
9.2.2 Conjugated mAbs
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Retail Pharmacies
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 F. Hoffmann-La Roche
10.1.2 Amgen
10.1.3 Bristol-Myers Squibb
10.1.4 Takeda Pharmaceuticals
10.1.5 Pfizer
10.1.6 Merck
10.1.7 Eli Lilly
10.1.8 Sanofi
10.1.9 Janssen Biotech
10.1.10 Novartis
10.1.11 AbbVie
10.1.12 Boehringer Ingelheim
10.1.13 AstraZeneca
10.1.14 Bayer
10.1.15 Biogen
10.1.16 TG Therapeutics
10.1.17 CTI BioPharma
10.1.18 Intas Pharmaceuticals
10.1.19 Kyowa Hakko Kirin
10.2 Cancer Monoclonal Antibodies Sales Date of Major Players (2017-2020e)
10.2.1 F. Hoffmann-La Roche
10.2.2 Amgen
10.2.3 Bristol-Myers Squibb
10.2.4 Takeda Pharmaceuticals
10.2.5 Pfizer
10.2.6 Merck
10.2.7 Eli Lilly
10.2.8 Sanofi
10.2.9 Janssen Biotech
10.2.10 Novartis
10.2.11 AbbVie
10.2.12 Boehringer Ingelheim
10.2.13 AstraZeneca
10.2.14 Bayer
10.2.15 Biogen
10.2.16 TG Therapeutics
10.2.17 CTI BioPharma
10.2.18 Intas Pharmaceuticals
10.2.19 Kyowa Hakko Kirin
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Cancer Monoclonal Antibodies Product Type Overview
2.Table Cancer Monoclonal Antibodies Product Type Market Share List
3.Table Cancer Monoclonal Antibodies Product Type of Major Players
4.Table Brief Introduction of F. Hoffmann-La Roche
5.Table Brief Introduction of Amgen
6.Table Brief Introduction of Bristol-Myers Squibb
7.Table Brief Introduction of Takeda Pharmaceuticals
8.Table Brief Introduction of Pfizer
9.Table Brief Introduction of Merck
10.Table Brief Introduction of Eli Lilly
11.Table Brief Introduction of Sanofi
12.Table Brief Introduction of Janssen Biotech
13.Table Brief Introduction of Novartis
14.Table Brief Introduction of AbbVie
15.Table Brief Introduction of Boehringer Ingelheim
16.Table Brief Introduction of AstraZeneca
17.Table Brief Introduction of Bayer
18.Table Brief Introduction of Biogen
19.Table Brief Introduction of TG Therapeutics
20.Table Brief Introduction of CTI BioPharma
21.Table Brief Introduction of Intas Pharmaceuticals
22.Table Brief Introduction of Kyowa Hakko Kirin
23.Table Products & Services of F. Hoffmann-La Roche
24.Table Products & Services of Amgen
25.Table Products & Services of Bristol-Myers Squibb
26.Table Products & Services of Takeda Pharmaceuticals
27.Table Products & Services of Pfizer
28.Table Products & Services of Merck
29.Table Products & Services of Eli Lilly
30.Table Products & Services of Sanofi
31.Table Products & Services of Janssen Biotech
32.Table Products & Services of Novartis
33.Table Products & Services of AbbVie
34.Table Products & Services of Boehringer Ingelheim
35.Table Products & Services of AstraZeneca
36.Table Products & Services of Bayer
37.Table Products & Services of Biogen
38.Table Products & Services of TG Therapeutics
39.Table Products & Services of CTI BioPharma
40.Table Products & Services of Intas Pharmaceuticals
41.Table Products & Services of Kyowa Hakko Kirin
42.Table Market Distribution of Major Players
43.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
44.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
45.Table Global Cancer Monoclonal Antibodies Market Forecast (Million USD) by Region 2021f-2026f
46.Table Global Cancer Monoclonal Antibodies Market Forecast (Million USD) Share by Region 2021f-2026f
47.Table Global Cancer Monoclonal Antibodies Market Forecast (Million USD) by Demand 2021f-2026f
48.Table Global Cancer Monoclonal Antibodies Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
